A trial to assess the effects of tiotropium bromide delivered via Handihaler or via Respimat in patients with COPD and chronic kidney disease
Latest Information Update: 17 Sep 2014
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
Most Recent Events
- 17 Sep 2014 New trial record